Shandong Pharmaceutical Glass Co Ltd - Asset Resilience Ratio
Shandong Pharmaceutical Glass Co Ltd (600529) has an Asset Resilience Ratio of 1.99% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 600529 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2025)
This chart shows how Shandong Pharmaceutical Glass Co Ltd's Asset Resilience Ratio has changed over time. See 600529 net asset quality score to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Shandong Pharmaceutical Glass Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Shandong Pharmaceutical Glass Co Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥202.19 Million | 1.99% |
| Total Liquid Assets | CN¥202.19 Million | 1.99% |
Asset Resilience Insights
- Limited Liquidity: Shandong Pharmaceutical Glass Co Ltd maintains only 1.99% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Shandong Pharmaceutical Glass Co Ltd Industry Peers by Asset Resilience Ratio
Compare Shandong Pharmaceutical Glass Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Packaging Corp of America
NYSE:PKG |
Packaging & Containers | 100.00% |
|
Ardagh Metal Packaging SA
NYSE:AMBP |
Packaging & Containers | 1.94% |
|
Zhejiang Zhongcheng Packing Material Co Ltd
SHE:002522 |
Packaging & Containers | 6.16% |
|
Shanghai Zijiang Enterprise Group Co Ltd
SHG:600210 |
Packaging & Containers | 1.02% |
|
Zhuhai Zhongfu Enterprise Co Ltd
SHE:000659 |
Packaging & Containers | -15.65% |
|
Nampak
JSE:NPK |
Packaging & Containers | 0.23% |
|
Berlina Tbk
JK:BRNA |
Packaging & Containers | 0.68% |
|
Worth Peripherals Limited
NSE:WORTHPERI |
Packaging & Containers | 11.16% |
Annual Asset Resilience Ratio for Shandong Pharmaceutical Glass Co Ltd (2014–2025)
The table below shows the annual Asset Resilience Ratio data for Shandong Pharmaceutical Glass Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 16.64% | CN¥1.67 Billion ≈ $244.56 Million |
CN¥10.04 Billion ≈ $1.47 Billion |
-0.37pp |
| 2024-12-31 | 17.01% | CN¥1.72 Billion ≈ $252.38 Million |
CN¥10.14 Billion ≈ $1.48 Billion |
+3.94pp |
| 2023-12-31 | 13.07% | CN¥1.22 Billion ≈ $178.22 Million |
CN¥9.32 Billion ≈ $1.36 Billion |
+0.53pp |
| 2022-12-31 | 12.54% | CN¥1.10 Billion ≈ $161.17 Million |
CN¥8.78 Billion ≈ $1.29 Billion |
+7.75pp |
| 2021-12-31 | 4.79% | CN¥307.13 Million ≈ $44.94 Million |
CN¥6.41 Billion ≈ $937.94 Million |
+0.69pp |
| 2020-12-31 | 4.10% | CN¥230.50 Million ≈ $33.73 Million |
CN¥5.62 Billion ≈ $822.59 Million |
-4.83pp |
| 2019-12-31 | 8.93% | CN¥461.84 Million ≈ $67.58 Million |
CN¥5.17 Billion ≈ $756.57 Million |
-8.11pp |
| 2018-12-31 | 17.04% | CN¥788.00 Million ≈ $115.31 Million |
CN¥4.62 Billion ≈ $676.59 Million |
-0.37pp |
| 2017-12-31 | 17.42% | CN¥728.00 Million ≈ $106.53 Million |
CN¥4.18 Billion ≈ $611.69 Million |
+12.81pp |
| 2016-12-31 | 4.61% | CN¥180.00 Million ≈ $26.34 Million |
CN¥3.90 Billion ≈ $571.31 Million |
+1.75pp |
| 2015-12-31 | 2.86% | CN¥85.00 Million ≈ $12.44 Million |
CN¥2.97 Billion ≈ $435.05 Million |
+0.48pp |
| 2014-12-31 | 2.38% | CN¥67.00 Million ≈ $9.80 Million |
CN¥2.82 Billion ≈ $412.39 Million |
-- |
About Shandong Pharmaceutical Glass Co Ltd
Shandong Pharmaceutical Glass Co.Ltd engages in research and development, production, and sale of various pharmaceutical glass packaging products in China. The company offers moulded glass products, including amber glass containers, dropper bottles, infusion bottles, cosmetic bottles, tablet bottle, food glass, cobalt blue and green bottles, and black bottles, as well as moulded glass injection v… Read more